CDK19 is a Regulator of Triple-Negative Breast Cancer Growth
Robert W. Hsieh, Angera H. Kuo, Ferenc A. Scheeren, Mark A. Zarnegar, Shaheen S. Sikandar, Jane Antony, Luuk S. Heitink, Divya Periyakoil, Tomer Kalisky, Sopheak Sim, Dalong Qian, Sanjay V. Malhotra, George Somlo, Frederick M. Dirbas, Ajit Jadhav, , Michael F. Clarke
This study identifies CDK19 as a therapeutic target for TNBC by showing its role in tumor growth and metastasis, with minimal impact on normal cells.
bioRxiv · May 10, 2018 · PreprintCancer Biology